Gillian Hawker1, Eric R Bohm2, Barbara Conner-Spady3, Carolyn De Coster3, Michael Dunbar4, Allan Hennigar4, Lynda Loucks5, Deborah A Marshall3, Marie-Pascale Pomey6, Claudia Sanmartin7, Tom Noseworthy3. 1. Women's College Hospital and University of Toronto, Toronto, Ontario, Canada. 2. University of Manitoba and Concordia Joint Replacement Group, Winnipeg, Manitoba, Canada. 3. University of Calgary, Calgary, Alberta, Canada. 4. Dalhousie University, Halifax, Nova Scotia, Canada. 5. Concordia Joint Replacement Group, Winnipeg, Manitoba, Canada. 6. University of Montreal, Montreal, Quebec, Canada. 7. University of Calgary, Calgary, Alberta, Canada, and Statistics Canada, Ottawa, Ontario, Canada.
Abstract
OBJECTIVE: As rates of total joint arthroplasty (TJA) for osteoarthritis (OA) rise, there is a need to ensure appropriate use. We undertook this study to develop criteria for appropriate use of TJA. METHODS: In prior work, we used qualitative methods to separately assess OA patients' and arthroplasty surgeons' perceptions regarding appropriateness of patient candidates for TJA. The current study reviewed the appropriateness themes that emerged from each group, and a series of statements were developed to reflect each unique theme or criterion. A group of arthroplasty surgeons then indicated their level of agreement with each statement using electronic voting. Where ≤70% agreed or disagreed, the criterion was discussed and revised, and revoting occurred. In standardized telephone interviews, OA patient focus group participants indicated their level of agreement with each revised criterion. RESULTS: Qualitative research in 58 OA patients and 14 arthroplasty surgeons identified 11 appropriateness criteria. Member-checking in 15 surgeons (including 5 who had participated in the qualitative study) resulted in agreement on 6 revised criteria. These included evidence of arthritis on joint examination, patient-reported symptoms negatively impacting quality of life, an adequate trial of appropriate nonsurgical treatment, realistic patient expectations of surgery, mental and physical readiness of patient for surgery, and patient-surgeon agreement that potential benefits exceed risks. Thirty-six of the original 58 OA patient focus group participants (62.1%) participated in the member-check interviews and endorsed all 6 criteria. CONCLUSION: Patients and surgeons jointly endorsed 6 criteria for assessment of TJA appropriateness in OA patients. Prospective validation of these criteria (assessed preoperatively) as predictive of postoperative patient-reported outcomes is under way and will inform development of a surgeon-patient decision-support tool for assessment of TJA appropriateness.
OBJECTIVE: As rates of total joint arthroplasty (TJA) for osteoarthritis (OA) rise, there is a need to ensure appropriate use. We undertook this study to develop criteria for appropriate use of TJA. METHODS: In prior work, we used qualitative methods to separately assess OA patients' and arthroplasty surgeons' perceptions regarding appropriateness of patient candidates for TJA. The current study reviewed the appropriateness themes that emerged from each group, and a series of statements were developed to reflect each unique theme or criterion. A group of arthroplasty surgeons then indicated their level of agreement with each statement using electronic voting. Where ≤70% agreed or disagreed, the criterion was discussed and revised, and revoting occurred. In standardized telephone interviews, OA patient focus group participants indicated their level of agreement with each revised criterion. RESULTS: Qualitative research in 58 OA patients and 14 arthroplasty surgeons identified 11 appropriateness criteria. Member-checking in 15 surgeons (including 5 who had participated in the qualitative study) resulted in agreement on 6 revised criteria. These included evidence of arthritis on joint examination, patient-reported symptoms negatively impacting quality of life, an adequate trial of appropriate nonsurgical treatment, realistic patient expectations of surgery, mental and physical readiness of patient for surgery, and patient-surgeon agreement that potential benefits exceed risks. Thirty-six of the original 58 OA patient focus group participants (62.1%) participated in the member-check interviews and endorsed all 6 criteria. CONCLUSION:Patients and surgeons jointly endorsed 6 criteria for assessment of TJA appropriateness in OA patients. Prospective validation of these criteria (assessed preoperatively) as predictive of postoperative patient-reported outcomes is under way and will inform development of a surgeon-patient decision-support tool for assessment of TJA appropriateness.
Authors: Jan Ostermann; Derek S Brown; Janine A van Til; Nick Bansback; France Légaré; Deborah A Marshall; Meenakshi Bewtra Journal: Patient Date: 2019-10 Impact factor: 3.883
Authors: S Décary; M Fallaha; B Pelletier; P Frémont; J Martel-Pelletier; J-P Pelletier; D E Feldman; M-P Sylvestre; P-A Vendittoli; F Desmeules Journal: BMC Musculoskelet Disord Date: 2017-11-14 Impact factor: 2.362
Authors: Barbara L Conner-Spady; Eric Bohm; Lynda Loucks; Michael J Dunbar; Deborah A Marshall; Tom W Noseworthy Journal: Qual Life Res Date: 2019-11-18 Impact factor: 4.147
Authors: Peter Cram; Bruce E Landon; John Matelski; Vicki Ling; Therese A Stukel; J Michael Paterson; Rajiv Gandhi; Gillian A Hawker; Bheeshma Ravi Journal: Arthritis Rheumatol Date: 2018-02-26 Impact factor: 10.995
Authors: Aileen M Davis; Selahadin Ibrahim; Sheilah Hogg-Johnson; Dorcas E Beaton; Bert M Chesworth; Rajiv Gandhi; Nizar N Mahomed; Anthony V Perruccio; Vaishnav Rajgopal; Rosalind Wong; James P Waddell Journal: CMAJ Open Date: 2018-07-19
Authors: Jeffrey B Driban; Lori Lyn Price; John Lynch; Michael Nevitt; Grace H Lo; Charles B Eaton; Timothy E McAlindon Journal: Clin Rheumatol Date: 2016-05-16 Impact factor: 2.980
Authors: Codie A Primeau; Trevor B Birmingham; Kristyn M Leitch; Kevin R Willits; Robert B Litchfield; Peter J Fowler; Jacquelyn D Marsh; Bert M Chesworth; Stephanie N Dixon; Dianne M Bryant; J Robert Giffin Journal: CMAJ Date: 2022-03-21 Impact factor: 16.859